TeamHealth to pay $60 million to settle overbilling allegations

Physician staffing company TeamHealth has agreed to pay a $60 million penalty to settle allegations that one of its subsidiaries told hospitalists to “up-code” and overbill Medicare, Medicaid and other federal programs.

According to the U.S. Department of Justice, North Hollywood, Calif.-based IPC, which was acquired by TeamHealth in 2015, “knowingly and systemically” encouraged hospital staff to bill for more than the services which were actually provided. It allegedly pressured hospitalists with lower billing levels to “catch up” to their peers involved in the scheme.

“Medical providers who fraudulently seek payments to which they are not entitled will be held accountable,” Zachary Fardon, U.S. Attorney for the Northern District of Illinois, said in a statement. “False documentation of treatment is not just flawed patient care; it is illegal.”

The federal government got involved in the case after it was brought to a court by a whistleblower, Bijan Oughatiyan, MD, who worked at IPC in San Antonio from 2003 to 2008. As part of the settlement, he’ll personally receive $11.8 million.

Besides the fine, TeamHealth agreed to a corporate integrity agreement with HHS’s Office of the Inspector General (OIG). Covering the company’s hospital medicine division, the agreement will aim to “increase TeamHealth’s accountability and transparency so that the company will avoid or promptly detect future fraud and abuse.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.